Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane M Da Silva

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16Laura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitroAndrew W Woodham, Adam B Raff, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
A major role for the minor capsid protein of human papillomavirus type 16 in immune escapeLaura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Intervirology|February 5, 2003
Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor preventionMark T Wakabayashi, Diane M Da Silva, Ronald K Potkul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunityDiane M Da Silva, Steven C Fausch, J Sjef Verbeek, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophagesRuben Prins, Daniel J Fernandez, Omid Akbari, et al.
American Journal of Obstetrics and Gynecology|July 17, 2021
Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern CaliforniaNeal M Lonky, Lanfang Xu, Diane M Da Silva, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
Human Vaccines & Immunotherapeutics|February 3, 2016
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseasesJoseph G Skeate, Andrew W Woodham, Mark H Einstein, et al.
The Journal of General Virology|June 6, 2015
A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumoursLies Bogaert, Andrew W Woodham, Diane M Da Silva, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16Laura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitroAndrew W Woodham, Adam B Raff, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
A major role for the minor capsid protein of human papillomavirus type 16 in immune escapeLaura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Intervirology|February 5, 2003
Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor preventionMark T Wakabayashi, Diane M Da Silva, Ronald K Potkul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunityDiane M Da Silva, Steven C Fausch, J Sjef Verbeek, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophagesRuben Prins, Daniel J Fernandez, Omid Akbari, et al.
American Journal of Obstetrics and Gynecology|July 17, 2021
Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern CaliforniaNeal M Lonky, Lanfang Xu, Diane M Da Silva, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
Human Vaccines & Immunotherapeutics|February 3, 2016
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseasesJoseph G Skeate, Andrew W Woodham, Mark H Einstein, et al.
The Journal of General Virology|June 6, 2015
A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumoursLies Bogaert, Andrew W Woodham, Diane M Da Silva, et al.
Pageof 7